| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |